Economic consulting firm CRA International (NASDAQ: CRAI) reported revenue ahead of Wall Street’s expectations in Q3 2026, with sales up 15.6% year on year to $214.9 million. The company’s full-year revenue guidance of $835 million at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $2.19 per share was 5.6% above analysts’ consensus estimates.

Is now the time to buy CRAI? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Charles River Associates delivered a robust third quarter, with the market reacting positively as revenue and profitability exceeded Wall Street expectations. Management credited the outperformance to strong demand across its core practices—especially Forensic Services, Life Sciences, and Antitrust & Competition Economics—which each posted double-digit growth. CEO Paul Maleh highlighted sustained client demand, noting, “Seven practices grew year-over-year, representing approximately 95% of the company’s total revenue for the third quarter.” The company’s ability to integrate new consultants rapidly and maintain high utilization rates further contributed to margin expansion, with operational execution enabling record profitability despite seasonal workforce transitions.

Looking ahead, management’s increased full-year revenue guidance is grounded in a healthy sales pipeline, continued hiring momentum, and robust project lead flow. Maleh emphasized that the acceleration in lead generation is not solely driven by artificial intelligence (AI) engagements, but rather by a combination of organic growth and rapid onboarding of new consultants. CFO Eric Nierenberg cautioned that, while the outlook is strong, the company remains mindful of uncertain macroeconomic and political conditions that could impact client demand. Management is also focused on mitigating the effects of rising non-cash expenses and regulatory tax changes in the upcoming quarters.

Key insights from management’s remarks

Management attributed the quarter’s success to high demand in legal, regulatory, and investigative services, rapid integration of new hires, and strong project pipelines across several business lines.

• Legal and regulatory demand surge: CRA’s legal and regulatory services saw significant growth, outpacing the broader legal market. Increased case filings and court judgments, along with new high-profile engagements in antitrust litigation, drove client activity in this segment.
• Forensic Services and crisis response: The Forensic Services practice achieved record revenue, supported by multiple crisis management projects, including regulatory matters for technology clients and AI-driven vulnerability testing for software companies. Management noted that preventative cybersecurity advisory is becoming a key growth area.
• Antitrust practice resilience: Despite a sequential slowdown in global M&A volume, the Antitrust & Competition Economics practice posted its seventh consecutive record quarter. Management attributed this to the practice’s role in high-stakes mergers and long-duration litigation, demonstrating resilience across shifting market conditions.
• Consultant headcount and utilization: The company expanded its consultant base by 6.2% year-over-year, with rapid integration of over 100 new hires. Utilization rates increased to 78%, reflecting both effective onboarding and sustained demand for services.
• Sales pipeline and lead flow: Average weekly project leads and new project originations grew more than 20% year-over-year, with management highlighting the expedited revenue impact from recent hires. Contributions came from both organic growth and the addition of new revenue-generating consultants.

Drivers of future performance

Management expects continued momentum from a strong sales pipeline, talent investments, and healthy demand for core consulting practices, but notes macroeconomic and regulatory risks remain.

• Talent-driven revenue expansion: Management believes the rapid onboarding and strong retention of new consultants will support further revenue growth. Maleh indicated the company will maintain measured headcount growth, aiming to sustain integration efficiency and high utilization rates without overextending resources.
• AI and cybersecurity advisory: While AI is not yet a direct driver of lead flow, management expects increased complexity in litigation and forensic work due to AI-related risks. Preventative cybersecurity services, including vulnerability testing, are viewed as an emerging growth opportunity for the Forensic Services practice.
• Macroeconomic and regulatory caution: Management cited persistent uncertainty in global economic and political conditions as a risk to client demand. Nierenberg highlighted ongoing tax regulation changes as an area of focus, with mitigation strategies in development to limit future impact on profitability.

Catalysts in upcoming quarters

Going forward, the StockStory team will be watching (1) whether CRA can maintain elevated utilization rates as new consultants are added, (2) if the Forensic Services and Antitrust & Competition Economics practices continue to deliver above-market growth despite industry fluctuations, and (3) management’s success in mitigating rising non-cash expenses and managing exposure to regulatory tax changes. The evolution of client demand for AI-related advisory and cybersecurity services will also be an important indicator of long-term growth.

CRA currently trades at $205.47, up from $194.75 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

Stocks that trumped tariffs

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.